(PharmaNewsWire.Com, November 06, 2019 ) The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period. Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.
This Research Report Examines:
> The integrated systems segment is expected to grow at the highest CAGR during the forecast period
> The software segment accounted for the largest share of the China cardiology information system market in 2018
> L3A hospitals accounted for the largest share of the China cardiology information system market in 2018
Key Benefits -
> Rising incidence of cardiovascular disease in China
> Government initiatives for HCIT development
> Increasing number of hospitals in China
The key players considered in the report are the following:
. Philips Healthcare (Netherlands)
. CREALIFE Medical Technology (China)
. Central Data Network (Australia)
. Infinitt Healthcare (South Korea)
. Esaote (Italy)
The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period. Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
